2SEVENTY BioTSVT
13F holders, Q2 2025 (June 30)2holders −137
0new positions
138sold out
$5.29avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding 2SEVENTY Bio Inc. (TSVT) in their 13F filings, down 137 from Q1 2025. 0 opened new positions and 138 sold out. The largest holders were Nuveen, LLC ($466K) and Osaic Holdings, Inc. ($42K).
- Company
- 2SEVENTY Bio Inc.
- CUSIP
- 901384107
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 138 | $233.9M |
All 13F filers, Q1 2025 → Q2 2025: 47,430,138 shares sold, net −47,430,138 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Nuveen, LLC | 0.00% | Reduce -10.2% | 93,115 | $466K |
| Osaic Holdings, Inc. | 0.00% | Reduce -6.3% | 2,857 | $42K |
"% of holder's portfolio" is TSVT's weight in each manager's 13F, not the share of 2SEVENTY Bio Inc. the manager owns.